Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 13:7:152.
doi: 10.3389/fncel.2013.00152.

Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements

Affiliations

Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements

Beatrice Paradiso et al. Front Cell Neurosci. .

Abstract

The transformation of a normal brain in epileptic (epileptogenesis) is associated with extensive morpho-functional alterations, including cell death, axonal and dendritic plasticity, neurogenesis, and others. Neurotrophic factors (NTFs) appear to be very strongly implicated in these phenomena. In this review, we focus on the involvement of fibroblast growth factor (FGF) family members. Available data demonstrate that the FGFs are highly involved in the generation of the morpho-functional alterations in brain circuitries associated with epileptogenesis. For example, data on FGF2, the most studied member, suggest that it may be implicated both in seizure susceptibility and in seizure-induced plasticity, exerting different, and apparently contrasting effects: favoring acute seizures but reducing seizure-induced cell death. Even if many FGF members are still unexplored and very limited information is available on the FGF receptors, a complex and fascinating picture is emerging: multiple FGFs producing synergic or antagonistic effects one with another (and/or with other NTFs) on biological parameters that, in turn, facilitate or oppose transformation of the normal tissue in epileptic. In principle, identifying key elements in these phenomena may lead to effective therapies, but reaching this goal will require confronting a huge complexity. One first step could be to generate a "neurotrophicome" listing the FGFs (and all other NTFs) that are active during epileptogenesis. This should include identification of the extent to which each NTF is active (concentrations at the site of action); how it is active (local representation of receptor subtypes); when in the natural history of disease this occurs; how the NTF at hand will possibly interact with other NTFs. This is extraordinarily challenging, but holds the promise of a better understanding of epileptogenesis and, at large, of brain function.

Keywords: cell death; epilepsy; fibroblast growth factors; neurogenesis; synaptogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of FGFs on morpho-functional alterations associated with epileptogenesis in the hippocampus. A schematic representation of some of the best-characterized effects of FGFs on the morpho-functional changes associated with epileptogenesis in the hippocampus: cell death, astrocytosis, blood-brain barrier (BBB) damage, alterations in synaptogenesis (density of excitatory or inhibitory terminals), axonal sprouting (like sprouting of the mossy fibers), aberrant neurogenesis with newborn neurons in the dentate gyrus hilus. Solid arrows indicate facilitation, dotted arrows inhibition of a specific event. The name of the FGF members is framed in red to indicate a putatively negative implication in epilepsy (favoring epileptogenesis), in green to indicate a putatively positive implication (contrasting epileptogenesis). Note that these are only tentative indications, because evidence regarding the FGFs is often fragmentary and because the patho-physiological consequences of each alteration are sometimes uncertain.

Similar articles

Cited by

References

    1. Abe K., Aoyagi A., Saito H. (2001). Sustained phosphorylation of mitogen-activated protein kinase is required for basic fibroblast growth factor-mediated axonal branch formation in cultured rat hippocampal neurons. Neurochem. Int. 38, 309–315 10.1016/s0197-0186(00)00093-0 - DOI - PubMed
    1. Acharya M. M., Hattiangady B., Shetty A. K. (2008). Progress in neuroprotective strategies for preventing epilepsy. Prog. Neurobiol. 84, 363–404 10.1016/j.pneurobio.2007.10.010 - DOI - PMC - PubMed
    1. Allerstorfer S., Sonvilla G., Fischer H., Spiegl-Kreinecker S., Gauglhofer C., Setinek U. (2008). FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene 27, 4180–4190 10.1038/onc.2008.61 - DOI - PMC - PubMed
    1. Aoyagi A., Nishikawa K., Saito H., Abe K. (1994). Characterization of basic fibroblast growth factor-mediated acceleration of axonal branching in cultured rat hippocampal neurons. Brain Res. 661, 117–126 10.1016/0006-8993(94)91188-6 - DOI - PubMed
    1. Ballabriga J., Pozas E., Planas A. M., Ferrer I. (1997). bFGF and FGFR-3 immunoreactivity in the rat brain following systemic kainic acid administration at convulsant doses: localization of bFGF and FGFR-3 in reactive astrocytes, and FGFR-3 in reactive microglia. Brain Res. 752, 315–318 10.1016/s0006-8993(96)01308-x - DOI - PubMed

LinkOut - more resources